Role of the T-cell interferon-gamma release assays in preventing reactivation of latent tuberculosis infection in immunosuppressed patients in treatment with anti-TNF agents

Journal of Crohn's and Colitis

Volumn 2, Issue 3, 2008, Pages 250-254

  Domínguez, Jose ^a   Latorre, Irene ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Anti TNF agents; Diagnosis; IGRA tests; Latent tuberculosis

Indexed keywords

ANTIGEN; AZATHIOPRINE; BCG VACCINE; CULTURE FILTRATE PROTEIN 10; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ANTIBODY;

ARTICLE; BACTERIAL STRAIN; BCG VACCINATION; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; COMPUTER ASSISTED TOMOGRAPHY; CROHN DISEASE; CYTOKINE RELEASE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FOOD AND DRUG ADMINISTRATION; HUMAN; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; INTERMETHOD COMPARISON; LUNG LAVAGE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TUBERCULOSIS;

EID: 49049110920     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2008.05.007     Document Type: Note

References (37)

1. Panes J., Gomollon F., Taxonera C., Hinojosa J., Clofent J., and Nos P. Crohn's disease: a review of current treatment with a focus on biologics. Drugs 67 (2007) 2511-2537
2. Keane J., Gershon S., Wise R.P., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med 345 (2001) 1098-1104
3. Gardam M.A., Keystone E.C., Menzies R., et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3 (2003) 148-155
4. Carmona L., Gomez-Reino J.J., Rodriguez-Valverde V., et al. Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52 (2005) 1766-1772
5. Jasmer R.M., Nahid P., and Hopewell P.C. Clinical practice. Latent tuberculosis infection. N Engl J Med 347 (2002) 1860-1866
6. Huebner R.E., Schein M.F., and Bass Jr. J.B. The tuberculin skin test. Clin Infect Dis 17 (1993) 968-975
7. Lee E., and Holzman R.S. Evolution and current use of the tuberculin test. Clin Infect Dis 34 (2002) 365-370
8. Targeted tuberculin testing and treatment of latent tuberculosis infection. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. This is a Joint Statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). This statement was endorsed by the Council of the Infectious Diseases Society of America. (IDSA), September 1999, and the sections of this statement. Am J Respir Crit Care Med 2000; 161: S221-47.
9. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159 (1999) 15-21
10. Ruiz-Manzano J., Blanquer R., Calpe J.L., et al. [Sociedad Española de Patologia Respiratoria guidelines: Diagnostic and treatment of tuberculosis]. First edn (2008), Elsevier España, S.L., Barcelona
11. Richeldi L. An update on the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 174 (2006) 736-742
12. Ponce de Leon D., Acevedo-Vasquez E., Sanchez-Torres A., et al. Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64 (2005) 1360-1361
13. Andersen P., Munk M.E., Pollock J.M., and Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet 356 (2000) 1099-1104
14. Lalvani A., Pathan A.A., McShane H., et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med 163 (2001) 824-828
15. Lalvani A., Nagvenkar P., Udwadia Z., et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 183 (2001) 469-477
16. Brock I., Weldingh K., Leyten E.M., Arend S.M., Ravn P., and Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of Mycobacterium tuberculosis infection. J Clin Microbiol 42 (2004) 2379-2387
17. Mow W.S., Abreu-Martin M.T., Papadakis K.A., Pitchon H.E., Targan S.R., and Vasiliauskas E.A. High incidence of anergy in inflammatory bowel disease patients limits the usefulness of PPD screening before infliximab therapy. Clin Gastroenterol Hepatol 2 (2004) 309-313
18. Ravn P., Munk M.E., Andersen A.B., et al. Prospective evaluation of a whole-blood test using Mycobacterium tuberculosis-specific antigens ESAT-6 and CFP-10 for diagnosis of active tuberculosis. Clin Diagn Lab Immunol 12 (2005) 491-496
19. Pai M., Joshi R., Dogra S., et al. Serial testing of health care workers for tuberculosis using interferon-gamma assay. Am J Respir Crit Care Med 174 (2006) 349-355
20. Mori T., Sakatani M., Yamagishi F., et al. Specific detection of tuberculosis infection: an interferon-gamma-based assay using new antigens. Am J Respir Crit Care Med 170 (2004) 59-64
21. Ferrara G., Losi M., D'Amico R., et al. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study. Lancet 367 (2006) 1328-1334
22. Ewer K., Deeks J., Alvarez L., et al. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 361 (2003) 1168-1173
23. Dominguez J., Ruiz-Manzano J., De Souza-Galvao M., et al. Comparison of two commercially available gamma interferon blood tests for immunodiagnosis of tuberculosis. Clin Vaccine Immunol 15 (2008) 168-171
24. Lalvani A., and Millington K.A. T cell-based diagnosis of childhood tuberculosis infection. Curr Opin Infect Dis 20 (2007) 264-271
25. Detjen A.K., Keil T., Roll S., et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 45 (2007) 322-328
26. Chapman A.L., Munkanta M., Wilkinson K.A., et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS 16 (2002) 2285-2293
27. Lange C., Hellmich B., Ernst M., and Ehlers S. Rapid immunodiagnosis of tuberculosis in a woman receiving anti-TNF therapy. N Clin Pract Rheumatol 3 (2007) 528-534
28. Matulis G., Juni P., Villiger P.M., and Gadola S.D. Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon gamma assay. Ann Rheum Dis 67 (2008) 84-90
29. Efthimiou P., and Sood S. QuantiFERON TB Gold Test: the new standard for screening of latent tuberculosis in patients with rheumatoid arthritis?. Ann Rheum Dis 66 (2007) 276
30. Cobanoglu N., Ozcelik U., Kalyoncu U., et al. Interferon-gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor-alpha blockers. Int J Tuberc Lung Dis 11 (2007) 1177-1182
31. Takahashi H., Shigehara K., Yamamoto M., et al. Interferon gamma assay for detecting latent tuberculosis infection in rheumatoid arthritis patients during infliximab administration. Rheumatol Int 27 (2007) 1143-1148
32. Richeldi L., Ewer K., Losi M., et al. Early diagnosis of subclinical multidrug-resistant tuberculosis. Ann Intern Med 140 (2004) 709-713
33. Wrighton-Smith P., and Zellweger J.P. Direct costs of three models for the screening of latent tuberculosis infection. Eur Respir J 28 (2006) 45-50
34. Menzies D., Pai M., and Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 146 (2007) 340-354
35. Lalvani A. Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy. Chest 131 (2007) 1898-1906
36. Ewer K., Millington K.A., Deeks J.J., Alvarez L., Bryant G., and Lalvani A. Dynamic antigen-specific T-cell responses after point-source exposure to Mycobacterium tuberculosis. Am J Respir Crit Care Med 174 (2006) 831-839
37. Diel R., Loddenkemper R., Meywald-Walter K., Niemann S., and Nienhaus A. Predictive value of a whole-blood IFN-gamma assay for the development of active TB disease. Am J Respir Crit Care Med 177 (2008) 1164-1170